A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine

V. Le Joncour, A. Martins, M. Puhka, J. Isola, M. Salmikangas, P. Laakkonen, H. Joensuu, M. Barok

Research output: Contribution to journalArticleScientificpeer-review

15 Citations (Scopus)
Original languageEnglish
Pages (from-to)1721-1730
JournalMolecular cancer therapeutics
Issue number10
Publication statusPublished - 2019
Publication typeA1 Journal article-refereed


  • HER2
  • T-DM1
  • XMT-1522
  • antibody-drug conjugate
  • breast cancer
  • gastric cancer

Publication forum classification

  • Publication forum level 1

Cite this